Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries

Cardiovascular Research

Volumn 42, Issue 3, 1999, Pages 743-751

  Lambert, Jan ^a   Van Den Berg, Michiel ^a   Steyn, Mieke ^a   Rauwerda, Jan A ^a   Donker, Ab J M ^a   Stehouwer, Coen D A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Elasticity; Endothelial function; Homocysteine; Nitric oxide; Vasodilation

Indexed keywords

HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTERY COMPLIANCE; ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; ELASTICITY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; ENDOTHELIUM, VASCULAR; FASTING; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; MIDDLE AGED; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; VASCULAR DISEASES; VASODILATION;

EID: 0032995052     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00338-1     Document Type: Article

References (46)

1. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995:1279-1327.
2. Clarke R., Daly L., Robinson K.et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. New Engl J Med. 324:1991;1149-1155.
3. Stamler J.S., Osborne J.A., Jaraki O.et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 91:1993;308-318.
4. Hajjar K.A. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest. 91:1993;2873-2879.
5. Stamler J.S., Loscalzo J. Endothelium-derived relaxing factor modulates the atherothrombogenic effects of homocysteine. J Cardiovasc Pharmacol. 20:1992;S202-S204.
6. Van den Berg M., Boers G.H.J., Franken D.G.et al. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest. 25:1995;176-181.
7. Celermajer D.S., Sorensen K., Ryalls M.et al. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol. 22:1993;854-858.
8. Tawakol A., Omland T., Gerhard M., Wu J.T., Creager M.A. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 95:1997;1119-1121.
9. McCully K.S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 56:1969;111-128.
10. Tsai J.-C., Perrella M.A., Yoshizumi M.et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA. 91:1994;6369-6373.
11. Van den Berg M., Franken D.G., Boers G.H.J.et al. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinaemia. J Vasc Surg. 20:1994;933-940.
12. De Jong S.C., Stehouwer C.D.A., MacKaay A.J.C.et al. High prevalence of hyperhomocysteinemia and asymptomatic vascular disease in siblings of young patients with vascular disease and hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 17:1997;2655-2662.
13. Chambers J.C., McGregor A., Jean-Marie J., Kooner J.S. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet. 351:1998;36-37.
14. Kool M.J., Lambert J., Stehouwer C.D., Hoeks A.P., Struyker Boudier H.A., Van Bortel L.M. Vessel wall properties of large arteries in uncomplicated IDDM. Diabetes Care. 18:1995;618-624.
15. Lambert J., Aarsen M., Donker A.J.M., Stehouwer C.D.A. Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 16:1996;705-711.
16. Celermajer D.S., Sorensen K.E., Gooch V.M.et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
17. Anderson E.A., Mark A.L. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation. 79:1989;93-100.
18. Graham I.M., Daly L.E., Refsum H.M.et al. Plasma Homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J Am Med Assoc. 277:1997;1775-1781.
19. Hoeks A.P.G., Brands P.J., Smeets F.A.M., Reneman R.S. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol. 16:1990;121-128.
20. Lehmann E.D., Hopkins K.D., Gosling R.G. Multiple definitions of "compliance" Clin Sci. 90:1996;433-434.
21. Peterson L.H., Jensen R.E., Parnell J. Mechanical properties of arteries in vivo. Circ Res. 8:1960;622-639.
22. Lambert J. Large artery function in insulin-dependent diabetes mellitus and hyperhomocysteinaemia. Amsterdam: Vrije Universiteit, Thesis:1997.
23. Kool M.J.F., Van Merode T., Reneman R.S., Hoeks A.P.G., Struyker Boudier H.A.J., Van Bortel L.M.A.B. Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties. Cardiovasc Res. 28:1994;619-624.
24. Ubbink J.B., Vermaak W.J.H., Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 565:1991;441-446.
25. Lambert J., Stehouwer C.D.A. Modulation of endothelium-dependent, flow-mediated dilatation of the brachial artery by sex and menstrual cycle (letter). Circulation. 94:1996;2319-2320.
26. Boers G.H.J., Smals A.G.H., Trijbels F.J.M.et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. New Engl J Med. 313:1985;709-715.
27. Stampfer M.J., Malinow M.R., Willett W.C.et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc. 268:1992;877-881.
28. Den Heijer M., Koster T., Blom H.J.et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New Engl J Med. 334:1996;759-762.
29. Lentz S.R., Sobey C.G., Piegors D.J.et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest. 98:1996;24-29.
30. de Jong S.C., Stehouwer C.D.A., van den Berg M., Vischer U.M., Rauwerda J.A., Emeis J.J. Endothelial marker proteins in hyperhomocysteinaemia. Thromb Haemostas. 78:1997;1332-1337.
31. Kamiya A., Togawa T. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol. 239:1980;H14-H21.
32. Tolins J.P., Shultz P.J., Raij L. Role of endothelium-derived relaxing factor in regulation of vascular tone and remodeling. Hypertension. 17:1991;909-916.
33. Joannides R., Haefeli W.E., Linder L.et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 91:1995;1314-1319.
34. Meredith I.T., Currie K.E., Anderson T.J., Roddy M.-A., Ganz P., Creager M.A. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol. 270:1996;H1435-H1440.
35. Anderson T.J., Uehata A., Gerhard M.D.et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26:1995;1235-1241.
36. Boers G.J. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease. Neth J Med. 45:1994;34-41.
37. Brattström L., Israelsson B., Norrving B.et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Atherosclerosis. 81:1990;51-60.
38. Selhub J., Miller J.W. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulphuration of homocysteine. Am J Clin Nutr. 55:1992;131-138.
39. Bostom A.G., Jacques P.F., Nadeau M.R., Williams R.R., Ellison R.C., Selhub J. Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study. Atherosclerosis. 116:1995;147-151.
40. 6 status, and premature thromboembolic disease (letter). Ann Int Med. 125:1996;419.
41. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 77:1986;1370-1376.
42. Perna A.F., Ingrosso D., Galletti P., Zappia V., De Santo N.G. Membrane protein damage and methylation reactions in chronic renal failure (editorial). Kidney Int. 50:1996;358-366.
43. Matthias D., Becker C.-H., Riezler R., Kindling P.H. Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine. Atherosclerosis. 122:1996;201-216.
44. Rolland P.H., Friggi A., Barlatier A.et al. Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation. 91:1995;1161-1174.
45. Joannides R., Richard V., Haefeli W.E.et al. Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans. Hypertension. 30:1997;1465-1470.
46. Blacher J., Demuth K., Guerin A.P., Safar M.E., Moatti N., London G.M. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol. 18:1998;535-541.